193 related articles for article (PubMed ID: 24262658)
21. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mTOR complexes protects cancer cells from glutamine starvation induced cell death by restoring Akt stability.
Khan MW; Layden BT; Chakrabarti P
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2040-2052. PubMed ID: 29555211
[TBL] [Abstract][Full Text] [Related]
23. Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines.
Dan VM; Muralikrishnan B; Sanawar R; J S V; Burkul BB; Srinivas KP; Lekshmi A; Pradeep NS; Dastager SG; Santhakumari B; Santhoshkumar TR; Kumar RA; Pillai MR
Sci Rep; 2018 Feb; 8(1):2810. PubMed ID: 29434241
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
Kadletz L; Bigenzahn J; Thurnher D; Stanisz I; Erovic BM; Schneider S; Schmid R; Seemann R; Birner P; Heiduschka G
Head Neck; 2016 Apr; 38 Suppl 1():E1918-25. PubMed ID: 26713885
[TBL] [Abstract][Full Text] [Related]
25. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
26. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
[TBL] [Abstract][Full Text] [Related]
27. Identification of natural product modulators of Merkel cell carcinoma cell growth and survival.
Smith EA; Hill NT; Gelb T; Garman KA; Goncharova EI; Bokesch HR; Kim CK; Wendt KL; Cichewicz RH; Gustafson KR; Brownell I; Henrich CJ
Sci Rep; 2021 Jun; 11(1):13597. PubMed ID: 34193920
[TBL] [Abstract][Full Text] [Related]
28. Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.
Yoon SO; Shin S; Karreth FA; Buel GR; Jedrychowski MP; Plas DR; Dedhar S; Gygi SP; Roux PP; Dephoure N; Blenis J
Mol Cell; 2017 Aug; 67(3):512-527.e4. PubMed ID: 28757207
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
Graab U; Hahn H; Fulda S
Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
[TBL] [Abstract][Full Text] [Related]
31. PDK1 is a potential therapeutic target against angiosarcoma cells.
Wada M; Horinaka M; Yasuda S; Masuzawa M; Sakai T; Katoh N
J Dermatol Sci; 2015 Apr; 78(1):44-50. PubMed ID: 25726712
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.
Bhat VK; Bernhart E; Plastira I; Fan K; Ghaffari-Tabrizi-Wizsy N; Wadsack C; Rechberger G; Eichmann T; Asslaber M; Spassova I; Verhaegen ME; Malle E; Becker JC; Sattler W
J Invest Dermatol; 2019 Apr; 139(4):807-817. PubMed ID: 30399362
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for Merkel Cell Carcinoma.
Nagase K; Narisawa Y
Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
[TBL] [Abstract][Full Text] [Related]
34. [Immune checkpoint inhibition in Merkel cell carcinoma].
Terheyden P; Mohr A; Langan EA
Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
[TBL] [Abstract][Full Text] [Related]
35. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.
Houben R; Shuda M; Weinkam R; Schrama D; Feng H; Chang Y; Moore PS; Becker JC
J Virol; 2010 Jul; 84(14):7064-72. PubMed ID: 20444890
[TBL] [Abstract][Full Text] [Related]
36. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.
Shuda M; Kwun HJ; Feng H; Chang Y; Moore PS
J Clin Invest; 2011 Sep; 121(9):3623-34. PubMed ID: 21841310
[TBL] [Abstract][Full Text] [Related]
37. Merkel cell carcinoma.
Wallis S; Durham-Hall A; Tandon N; Brotherston TM; Shrestha BM
JNMA J Nepal Med Assoc; 2010; 49(178):151-4. PubMed ID: 21485603
[TBL] [Abstract][Full Text] [Related]
38. Identification and optimization of 3-bromo-N'-(4-hydroxybenzylidene)-4-methylbenzohydrazide derivatives as mTOR inhibitors that induce autophagic cell death and apoptosis in triple-negative breast cancer.
Xu T; Zhang J; Yang C; Pluta R; Wang G; Ye T; Ouyang L
Eur J Med Chem; 2021 Jul; 219():113424. PubMed ID: 33862514
[TBL] [Abstract][Full Text] [Related]
39. Dihydroartemisinin, an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells.
Shi X; Wang L; Ren L; Li J; Li S; Cui Q; Li S
Phytother Res; 2019 May; 33(5):1413-1425. PubMed ID: 30873702
[TBL] [Abstract][Full Text] [Related]
40. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
